Status:
COMPLETED
D2 Versus D1 Gastrectomy of Operable Gastric Cancer
Lead Sponsor:
Alexandria University
Conditions:
Gastric Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
Surgery is the mainstay treatment of operable gastric carcinoma but the optimal extent of lymph node (LN) dissection is controversial. The aim of this observational study is to assess the outcomes aft...
Detailed Description
This observational study included 80 consecutive patients presented by operable gastric cancer treated by D2 gastrectomy at Alexandria University hospital between January 2010 and January 2016, (Group...
Eligibility Criteria
Inclusion
- Patients younger than 80 years with a histologically confirmed operable adenocarcinoma of the stomach with complete follow up after surgery for average 5 years
Exclusion
- Complicated gastric cancer (obstructed or perforated)
- Irresectable or metastatic disease
- Previous or coexisting cancer
- Prior gastric surgery.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2020
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT04429841
Start Date
January 1 2010
End Date
June 1 2020
Last Update
June 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria, Egypt